Skip to main content
. 2022 Oct 26;11(21):6320. doi: 10.3390/jcm11216320

Table 1.

Patient characteristics.

Characteristics CYP3A5 Expressers
(n = 110)
CYP3A5 Nonexpressers
(n = 78)
p-Value
On the day of transplantation
Recipient age, years 45.8 ± 11.7 44.7 ± 11.6 0.538 b
Body weight, kg 58.2 ± 11.2 58.0 ± 11.7 0.889 b
Female, n (%) 49 (44.5) 35 (44.9) 0.965 a
Previous KT, n (%) 7 (6.4) 3 (3.8) 0.527 c
Panel reactive antibody > 20%, n (%) 19 (17.3) 12 (15.4) 0.731 a
Human leukocyte antigen mismatches, no. 3.0 [2.0, 4.0] 3.0 [2.0, 4.0] 0.973 d
Deceased donor, n (%) 56 (50.9) 36 (46.2) 0.520 a
Donor age, years 36.5 [28.8, 46.2] 38.0 [28.2, 46.2] 0.723 d
Cold ischemic time, minutes 253.5 [20.8, 1078.5] 68.0 [21.5, 1047.0] 0.907 d
Renal replacement therapy before KT, n (%) - - 0.234 c
Preemptive transplantation 2 (1.8) 4 (5.1) -
Hemodialysis 97 (88.2) 70 (89.7) -
Peritoneal dialysis 11 (10.0) 4 (5.1) -
At month 6 post-kidney transplantation
Serum creatinine, mg/dL 1.3 [1.0, 1.6] 1.2 [1.0, 1.5] 0.377 d
Hemoglobin, g/dL 12.9 ± 1.8 13.2 ± 1.8 0.353 b
Serum albumin, g/dL e 4.3 [4.1, 4.6] 4.3 [4.2, 4.6] 0.495 d
At month 9 post- kidney transplantation
Serum creatinine, mg/dL 1.3 [1.0, 1.5] 1.2 [1.0, 1.5] 0.475 d
Hemoglobin, g/dL 13.2 ± 1.8 13.5 ± 1.8 0.272 b
Serum albumin, g/dL f 4.4 [4.2, 4.6] 4.4 [4.2, 4.6] 0.742 d
At month 12 post- kidney transplantation
Serum creatinine, mg/dL 1.3 [1.0, 1.5] 1.2 [1.0, 1.5] 0.327 d
Hemoglobin, g/dL 13.4 ± 1.7 13. 6 ± 1. 7 0.421 b
Serum albumin, g/dL g 4.4 [4.2, 4.6] 4.4 [4.3, 4.7] 0.527 d

Continuous values are expressed as mean ± SD or median [interquartile range] for comparison reasons. a Chi-square test. b Student’s t-test. c Fisher’s exact test. d Mann–Whitney U test. e Serum albumin at month 6 was that of 137 patients only. f Serum albumin at month 9 was that of 128 patients only. g Serum albumin at month 12 was that of 125 patients only.